An interventional study of 3-snip punctoplasty and 3-snip punctoplasty and Mitomycin C in Punctal Stenosis, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 16 Years to 63 Years. Per ClinicalTrials.gov, last updated 2022-10-19.
Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment
Punctal stenosis is a progressive constriction of the puncta with resultant epiphora. One of the most effective treatment options is 1- to 4-snip punctoplasty combined with or without Mitomycin-C.
1,117 studies on the registry are indexed under Constriction, Pathologic; 231 are open to participants now.
This study's enrollment of 18 is below the median of 80 across 672 interventional studies indexed under Constriction, Pathologic.
Browse Constriction, Pathologic studies →Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: 3-snip punctoplasty
Procedure: 3-snip punctoplasty and Mitomycin C
punctoplasty, more commonly known as watery eye surgery, is an ophthalmic surgical procedure performed to correct punctal stenosis (a condition that causes tears to overflow from the eyes) by widening the punctal opening to allow the tears to drain with ease.
punctoplasty, more commonly known as watery eye surgery, is an ophthalmic surgical procedure performed to correct punctal stenosis (a condition that causes tears to overflow from the eyes) by widening the punctal opening to allow the tears to drain with ease. Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis
Punctal patency
Punctum will be assessed by inspection of the lid by slitlamb examination, whither obstructed or not
Time frame: Baseline
Punctal patency
Punctum will be assessed by inspection of the lid by slitlamb examination, whither obstructed or not
Time frame: 1 week postoperative
Punctal patency
Punctum will be assessed by inspection of the lid by slitlamb examination, whither obstructed or not
Time frame: 1 month postoperative
Punctal patency
Punctum will be assessed by inspection of the lid by slitlamb examination, whither obstructed or not
Time frame: 3 months postoperative
Presence of Epiphora
It will be assessed by inspection of the lid by slitlamb examination.
Time frame: Baseline
Presence of Epiphora
It will be assessed by inspection of the lid by slitlamb examination.
Time frame: 1 week postoperative
Presence of Epiphora
It will be assessed by inspection of the lid by slitlamb examination.
Time frame: 1 month postoperative
Presence of Epiphora
It will be assessed by inspection of the lid by slitlamb examination.
Time frame: 3 month postoperative
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Al-Azhar University